By A Mystery Man Writer
MD Anderson research shows modern chemotherapies are tied to a small but significant increased risk of secondary MDS and AML in older breast cancer patients. These findings may help oncologists understand their patients’ risks and better inform discussions with them.
Chemo-free drug combo shows 'dramatic' improvement against common leukemia in adults
How serious is FDA warning about revolutionary blood-cancer treatment?— Harvard Gazette
Understanding Leukemia Relapse
Leukemia: Coping, Support, and Living Well
Managing Side Effects of Leukemia Treatment in Children
Chemotherapy sometimes set the stage for drug-resistant leukemia at relapse
Do modern chemo drugs raise the risk of leukemia in some older patients?
Cancer drug shortage: Price gouging of chemo drugs hits some hospitals hard
Leukemia in Infants: Understanding This Rare Condition
Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics - ScienceDirect
/thmb/oY00QlqAA5bAH7yvFz_fCN
For Children With Cancer, Hope for New Treatments - WSJ
Leukemia Risk Factors
Which Workplace Chemicals Raise the Risk for Leukemia?